Cargando…
Synthesis and Structure–Activity Relationship of Dehydrodieugenol B Neolignans against Trypanosoma cruzi
[Image: see text] Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the...
Autores principales: | Sear, Claire E., Pieper, Pauline, Amaral, Maiara, Romanelli, Maiara M., Costa-Silva, Thais A., Haugland, Marius M., Tate, Joseph A., Lago, João H. G., Tempone, Andre G., Anderson, Edward A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670487/ https://www.ncbi.nlm.nih.gov/pubmed/33047947 http://dx.doi.org/10.1021/acsinfecdis.0c00523 |
Ejemplares similares
-
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
por: Amaral, Maiara, et al.
Publicado: (2023) -
Piperazine amides with desirable solubility, physicochemical and drug-like properties: Synthesis and evaluation of the anti-Trypanosoma cruzi activity
por: Varela, Marina T., et al.
Publicado: (2023) -
Mitochondrial Imbalance
of Trypanosoma
cruzi Induced by the Marine Alkaloid 6-Bromo-2′-de-N-Methylaplysinopsin
por: Romanelli, Maiara M., et al.
Publicado: (2022) -
Crystal structure of Dehydrodieugenol B methyl ether, a neolignan from Nectandra leucantha Nees and Mart (Lauraceae)
por: Grecco, Simone S., et al.
Publicado: (2018) -
Synthetic Analogues of Gibbilimbol B Induce Bioenergetic Damage and Calcium Imbalance in Trypanosoma cruzi
por: Amaral, Maiara, et al.
Publicado: (2023)